Clinical Trial: Medicine-induced Cardiac Hemodialysis on COVID-19
Study Status: Completed
Recruit Status: Completed
Condition:
Severe Acute Respiratory Syndrome-related Coronavirus
Renal Dialysis
Vaccines
Myocard
Study Type: Interventional
Official Title: Cardiac Transfer of SARS-CoV-2 Spike Protein Circulation Techniques - Medicine Induced Hemodialysis on "Vaccinated" Immune Attacks
Brief Summary:
The clinical trial studies the human pathogen of SARS-CoV-2, with a specificity in the circulating Spike 2 protein in the human system. The clinical trial hypothesizes that SARS-CoV-2 human pathogen arises from immune attacks, underlying the severe physiological symptoms that can be lethal. It further hypothesizes that the vaccines do not deal with the Spike 2 protein that causes the immune attacks.
Read more